Routine heart ultrasound measurements of left ventricular (LV) underfilling may significantly improve the prediction of poorer outcomes in people with…
Articles by Michela Luciano, PhD
Tiakis Biotech is set to advance its experimental therapy tiprelestat into a Phase 2 clinical trial for pulmonary…
Researchers in the U.S. have found that exposure to low oxygen levels — known as hypoxia — early in life…
Cereno Scientific is seeking a green light from the U.S. Food and Drug Administration (FDA) to launch a global…
The first clinical site is now active for a global Phase 3 study that will evaluate Gossamer Bio’s therapy…
An eight-week exercise program using kettlebells — a weight tool consisting of a heavy cast-iron ball and handle — led…
People with portopulmonary hypertension (PoPH), a form of pulmonary arterial hypertension (PAH) usually associated with liver disease, show lower…
The first participant has been dosed in a Phase 1 trial testing F230, an investigational oral therapy for pulmonary…
The U.S. Food and Drug Administration (FDA) has granted breakthrough device status to the Gradient Denervation System, an ultrasound-based catheter…